Chapter 1: Introduction
1.1. Report Description
1.1. Key Benefits for Stakeholders
1.2. Key Market Segments
1.2.1. List of Key Players Profiled in the Report
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. CXO Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Top Player Positioning, 2019
3.4. Porter’sFive Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Growing Number of Cross Industry Collaborations and Partnerships
3.5.1.2. Artificial Intelligence Reduces Cost and Time Utilized in the Drug Discovery& Development Process.
3.5.2. Restraints
3.5.2.1. Lack of Skilled Professionals
3.5.2.2. Lack of Data Sets in the Field of Drug Discovery
3.5.3. Opportunity
3.5.3.1. Increase in Awareness Related to Artificial Intelligence
3.5.3.2. Untapped Market in Developing Regions
3.5.4. Impact Analysis
Chapter 4: Artificial Intelligence for Drug Discovery and Development Market, by Type
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Target Identification
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Molecule Screening
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Analysis, by Country
4.4. De Novo Drug Design and Drug Optimization
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
4.5. Preclinical and Clinical Testing
4.5.1. Key Market Trends, Growth Factors, and Opportunities
4.5.2. Market Size and Forecast, by Region
4.5.3. Market Analysis, by Country
Chapter 5: Artificial Intelligence for Drug Discovery and Developmentmarket, by Indication
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Oncology
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Neurology
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Infectious Disease
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
5.5. Others
5.5.1. Market Size and Forecast, by Region
5.5.2. Market Analysis, by Country
Chapter 6: Artificial Intelligence for Drug Discovery and Development, by End-user
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Pharmaceutical and Biotechnology Companies
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Contract Research Organization
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
Chapter 7: Global Artificial Intelligence for Drug Discovery and Development Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.2.2. North America Artificial Intelligence for Drug Discovery and Development , by Country
7.2.2.1. U. S.
7.2.2.1.1. U. S. Artificial Intelligence for Drug Discovery and Development Market, by Type
7.2.2.1.2. U. S Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.2.2.1.3. U. S. Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.2.2.2. Canada
7.2.2.2.1. Canada Artificial Intelligence for Drug Discovery and Development Market, by Type
7.2.2.2.2. Canada Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.2.2.2.3. Canada Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.2.3. North America Artificial Intelligence for Drug Discovery and Development Market, by Type
7.2.4. North America Artificial Intelligence for Drug Discovery and Development , by Indication
7.2.5. North America Artificial Intelligence for Drug Discovery and Development , by End-user
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, and Opportunities
7.3.2. Europe Artificial Intelligence for Drug Discovery and Development , by Country
7.3.2.1. UK Artificial Intelligence for Drug Discovery and Development Market, by Type
7.3.2.1.1. UK Artificial Intelligence for Drug Discovery and Development Market, by Type
7.3.2.1.2. UK Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.3.2.1.3. UK Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.3.2.2. Germany
7.3.2.2.1. Germany Artificial Intelligence for Drug Discovery and Development Market, by Type
7.3.2.2.2. Germany Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.3.2.2.3. Germany Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.3.2.3. France
7.3.2.3.1. France Artificial Intelligence for Drug Discovery and Development Market, by Type
7.3.2.3.2. France Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.3.2.3.3. France Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.3.2.4. Rest of Europe
7.3.2.4.1. Rest of Europe Artificial Intelligence for Drug Discovery and Development Market, by Type
7.3.2.4.2. Rest of Europe Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.3.2.4.3. Rest of Europe Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.3.3. Europe Artificial Intelligence for Drug Discovery and Development , by Type
7.3.4. Europe Artificial Intelligence for Drug Discovery and Development , by Indication
7.3.5. Europe Artificial Intelligence for Drug Discovery and Development , by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, and Opportunities
7.4.2. Asia-Pacific Artificial Intelligence for Drug Discovery and Development , by Country
7.4.2.1. Japan
7.4.2.1.1. Japan Artificial Intelligence for Drug Discovery and Development Market, by Type
7.4.2.1.2. Japan Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.4.2.1.3. Japan Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.4.2.2. China
7.4.2.2.1. China Artificial Intelligence for Drug Discovery and Development Market, by Type
7.4.2.2.2. China Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.4.2.2.3. China Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.4.2.3. Australia
7.4.2.3.1. . Australia Artificial Intelligence for Drug Discovery and Development Market, by Type
7.4.2.3.2. Australia Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.4.2.3.3. Australia Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.4.2.4. India
7.4.2.4.1. India Artificial Intelligence for Drug Discovery and Development Market, by Type
7.4.2.4.2. India Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.4.2.4.3. India Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.4.2.5. Rest of Asia-Pacific
7.4.2.5.1. Rest of Asia-Pacific Artificial Intelligence for Drug Discovery and Development Market, by Type
7.4.2.5.2. Rest of Asia-Pacific Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.4.2.5.3. Rest of Asia-Pacific Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.4.3. Asia-Pacific Artificial Intelligence for Drug Discovery and Development , by Type
7.4.4. Asia-Pacific Artificial Intelligence for Drug Discovery and Development , by Indication
7.4.5. Asia-Pacific Artificial Intelligence for Drug Discovery and Development , by End-user
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, and Opportunities
7.5.2. LAMEA Artificial Intelligence for Drug Discovery and Development , by Country
7.5.2.1. Latin America
7.5.2.1.1. Latin America Artificial Intelligence for Drug Discovery and Development Market, by Type
7.5.2.1.2. Latin America Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.5.2.1.3. Latin America Artificial Intelligence for Drug Discovery and Development Market, by End-user
7.5.2.2. Middle East and Africa
7.5.2.2.1. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market, by Type
7.5.2.2.2. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market, by Indication
7.5.2.2.3. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market, by End-user
Chapter 8: Company Profiles
8.1. Alphabet Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.2. Atomwise, Inc.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segment
8.2.4. Product Portfolio
8.2.5. Key Strategic Moves and Developments
8.3. Benevolent Ai
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segment
8.3.4. Product Portfolio
8.3.5. Key Strategic Moves and Developments
8.4. Cloud Pharmaceutical
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segment
8.4.4. Product Portfolio
8.4.5. Key Strategic Moves and Developments
8.5. Deep Genomics
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segment
8.5.4. Product Portfolio
8.6. Exscientia.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segment
8.6.4. Product Portfolio
8.6.5. Key Strategic Moves and Developments
8.7. IBM Corporation
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.7.6. Key Strategic Moves and Developments
8.8. Insilico Medicine Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segment
8.8.4. Product Portfolio
8.8.5. Key Strategic Moves and Developments
8.9. Microsoft Corporation
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.9.6. Key Strategic Moves and Developments
8.10. Nvidia Corporation
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance